BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, January 15, 2025
Home
»
Topics
»
Disease categories and therapies
» Cancer
Cancer
RSS
Hughes Institute enters licensing agreement for anticancer drug development
Feb. 9, 1999
No Comments
Boston Life Sciences identifies a second antiangiogenic molecule
Feb. 8, 1999
No Comments
Orphan Medical's Busulfex Injection approved in U.S.
Feb. 8, 1999
No Comments
Lorus Therapeutics announces preclinical data on anticancer compound
Feb. 8, 1999
No Comments
Aronex's NDA for Atragen accepted for review
Feb. 5, 1999
No Comments
Vitaxin proceeds to phase II
Feb. 5, 1999
No Comments
First phase I clinical trials commence with NX-211
Feb. 4, 1999
No Comments
Preclinical study of TRAIL points to promise as antitumor agent
Feb. 4, 1999
No Comments
Ontogen completes phase I study of MDR-modulating compound
Feb. 3, 1999
No Comments
First NDA filing for Prevatac expected to be delayed
Feb. 2, 1999
No Comments
Previous
1
2
…
3605
3606
3607
3608
3609
3610
3611
3612
3613
…
3829
3830
Next
RSS